Digital Platform by My mhealth Enhances Chronic Disease Management
London, Friday, 8 August 2025.
My mhealth revolutionizes chronic care with its digital platform for conditions like COPD, showing impressive activation rates and reducing hospital admissions, supported by NHS in the UK.
Transformative Technology in Chronic Disease Management
The digital-therapeutic platform developed by my mhealth is making significant strides in the management of chronic diseases such as chronic obstructive pulmonary disease (COPD). Their platform, myCOPD, is unique in that it is the only digital treatment for lung conditions with formal market approval, supported by the NHS through the Innovation and Technology Tariff. This support has facilitated the widespread adoption of the platform, which has been shown to reduce hospital admissions and support clinical care, marking a significant improvement in patient outcomes [1].
Personalized Healthcare and Remote Monitoring
My mhealth’s platform leverages personalized treatment plans and remote monitoring capabilities to empower patients. Claire Donnelly, Chief Strategy Officer of my mhealth, highlighted that their technology was built to give patients greater control over their conditions while supporting clinicians with better tools and insights [1]. This approach addresses a longstanding challenge in healthcare—delivering continuous, high-quality care to individuals with chronic diseases at scale. Recent trials have shown activation rates as high as 88%, a stark contrast to the industry benchmark of 30%, underscoring the platform’s effectiveness and user engagement [1].
Expansion and Future Prospects in the Healthcare Ecosystem
Since its inception, my mhealth has expanded internationally, launching commercially in US states such as Florida and Massachusetts, with ongoing trials in Kansas [1]. Their international expansion is supported by funding secured through a successful Eurostars bid in 2024, amounting to €594,599. Innovate UK’s Business Growth and Global Explorer programs have played a pivotal role in this process by providing the necessary structure, focus, and connections to scale effectively [1].
Addressing Scalability and Integration in Global Health Markets
The success of my mhealth’s platform is indicative of broader trends in digital health. The increasing reliance on digital solutions like eHealth, mHealth, telehealth, and uHealth—collectively forming part of Healthcare 4.0—demonstrates the growing importance of technology in improving healthcare delivery and patient outcomes [2]. This integration of digital therapeutics within established healthcare systems, such as the NHS’s support of myCOPD, showcases the potential for digital health platforms to become pivotal components of chronic disease management strategies globally [1][2][3].